BFG
TECH icon

Bleakley Financial Group’s Bio-Techne TECH Stock Holding History

Bleakley Financial Group’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,636
Closed -$262K – 941
2024
Q4 		$262K Sell
3,636
-137
-4% -$10.1K 0.01% 848
2024
Q3 		$302K Buy
3,773
+214
+6% +$16.1K 0.01% 776
2024
Q2 		$255K Buy
3,559
+455
+15% +$33.5K 0.01% 805
2024
Q1 		$218K Buy
3,104
+301
+11% +$21.5K 0.01% 864
2023
Q4 		$216K Buy
+2,803
New +$185K 0.01% 837
2023
Q3 		– Sell
-2,947
Closed -$241K – 951
2023
Q2 		$241K Buy
+2,947
New +$237K 0.01% 790
2023
Q1 		– Sell
-3,279
Closed -$272K – 949
2022
Q4 		$272K Buy
+3,279
New +$260K 0.01% 722

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Bleakley Financial Group's TECH Position: Q1 2025 in Review

Bleakley Financial Group sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 3,636 shares — an estimated $262K sold.

Bleakley Financial Group first reported a position in TECH in Q4 2022 and held it in 7 quarters. The position peaked at $302K in Q3 2024. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

  • Bleakley Financial Group reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
  • Bleakley Financial Group sold 3,636 Bio-Techne shares in Q1 2025, an estimated $262K.
  • Bleakley Financial Group first reported a position in Bio-Techne in Q4 2022 and held it in 7 quarters.
  • Bleakley Financial Group's Bio-Techne position peaked at $302K in Q3 2024.
  • 578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Bleakley Financial Group's 13F filing for Q1 2025, filed 1 May 2025.